Companies: 10,795·Total market cap: $144.5T
Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.

ELDNNASDAQHealthcare● Active
$3.58
+$0.17(+4.99%)
Market Cap$214618469
P/E Ratio
52W High$4.6
52W Low$1.35

Eledon Pharmaceuticals, Inc.(ELDN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

eldn · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

SellBuy

Buy

4 位分析师

共识

评级分布

Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
合计: 4 · 买入占比: 100.0%

12 个月目标价

High

$5.00

Consensus

$5.00

+39.7% upside

Low

$5.00

Median: $5 · Last Close: $3.58

Eledon Pharmaceuticals, Inc.(ELDN)的分析师共识为 Buy,基于过去 3 个月内 4 位华尔街分析师的评级。ELDN 的 12 个月平均目标价为 $5.00,相对当前价 $3.58 代表 +39.7% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$3.405.00%

1-day model range: $3.38–$3.42. Peak: $3.42 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%21%36%
6Buy
3Neutral
5Sell
RSI (14)50.0Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ELDN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$3.52BUY
MA 10$3.68SELL
MA 20$3.75SELL
MA 50$3.57BUY
MA 100$2.99BUY
MA 200$0.00NEUTRAL
Current $ELDN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.56BUY
EMA 10$3.63SELL
EMA 20$3.68SELL
EMA 50$3.50BUY
EMA 100$3.03BUY
EMA 200$0.00NEUTRAL
Current $ELDN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Guggenheim2025-11-18
Maintains
BuyBuy
HC Wainwright & Co.2025-09-02
Maintains
BuyBuy
HC Wainwright & Co.2024-11-20
Maintains
BuyBuy
HC Wainwright & Co.2024-06-04
Maintains
BuyBuy
HC Wainwright & Co.2024-05-10
Maintains
BuyBuy
HC Wainwright & Co.2024-05-07
Maintains
BuyBuy
HC Wainwright & Co.2024-03-22
Maintains
BuyBuy
HC Wainwright & Co.2023-11-13
Maintains
BuyBuy
HC Wainwright & Co.2023-10-24
Maintains
BuyBuy
Cantor Fitzgerald2023-08-22
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Eledon Pharmaceuticals, Inc. (ELDN) stock. Of the recent 16 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ELDN.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ELDN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$0M

↓ 100.0% YoY

Revenue Next Year

$0M

EPS This Year

$-0.87

EPS Next Year

$-0.78

↓ 10.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ELDN EPS of $-0.87 for the current fiscal year, based on estimates from 3 analysts. The ELDN revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ELDN 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ELDN 的共识目标价为 $5.00(+39.7% 上行空间),分析师共识为 Buy。

ELDN 的短期预测(明日)为 $3.40(-5.00%)。

Eledon Pharmaceuticals, Inc. 在 NASDAQ 上市,代码 ELDN。ELDN 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ELDN 预测 · 8 个问题

根据 4 位华尔街分析师,ELDN 的 12 个月平均目标价为 $5.00,最高 $5.00、最低 $5.00。若有图表,中位目标价可在上方查看。相对当前价 $3.58,隐含约 +39.7% 的上行空间。

ELDN 目标价ELDN 分析师目标价ELDN 12个月目标价目标价 ELDN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.